Skip to main content
Clinical Trials/NCT00171041
NCT00171041
Completed
Phase 3

A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertensive Patients

Novartis1 site in 1 country265 target enrollmentDecember 2002
ConditionsHypertension

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hypertension
Sponsor
Novartis
Enrollment
265
Locations
1
Primary Endpoint
Change from baseline in sitting systolic blood pressure after 2 weeks
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Drugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) grant permission to participate.

Registry
clinicaltrials.gov
Start Date
December 2002
End Date
March 2006
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Novartis
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • CHILDREN HAVE SYSTOLIC BLOOD PRESSURE AT A LEVEL =\>95th PERCENTILE FOR AGE/GENDER/HEIGHT
  • CONSENT FROM PARENT(S)/GUARDIAN(S) MUST BE GRANTED

Exclusion Criteria

  • BLOOD PESSURE IS =\>5% HIGHER THAN 99th PERCENTILE FOR AGE
  • SERIOUS, CLINICALLY SIGNIFICANT FINDINGS UPON PHYSICAL EXAMINATION, AND LABORATORY AND OTHER ASSESSMENTS
  • Other protocol-defined inclusion/exclusion criteria will also apply.

Outcomes

Primary Outcomes

Change from baseline in sitting systolic blood pressure after 2 weeks

Secondary Outcomes

  • Change in diastolic blood pressure after 2 weeks to 4 weeks
  • Change from baseline diastolic blood pressure after 2 weeks
  • Change from baseline systolic blood pressure after 4 weeks
  • Change from baseline diastolic blood pressure after 4 weeks
  • Change from baseline systolic and diastolic blood pressure after 4 weeks and 52 weeks

Study Sites (1)

Loading locations...

Similar Trials